Riskpilot← Back to searchSign inGet full accessJatros nord AB
ABActiveOrg 5567867972Alstigen 2Medical specialists activities · NACE 8622Est. 20090 employees
Revenue 2024
SEK 2,6M
-21% vs 2023
EBITDA margin
-15.1%
-186% vs 2023
Equity ratio
-171.1%
Financial strength
Net profit 2024
SEK -489K
-241% vs 2023
| Revenue | SEK 2,6M | -21% |
| EBITDA | SEK -395K | -186% |
| Net profit | SEK -489K | -241% |
| Total assets | SEK 425K | -31% |
| Equity | SEK -727K | -205% |
| Employees | 0 | — |
Legal name
Jatros nord AB
Org number
5567867972
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 augusti 2009
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska utföra läkartjänster och konsultationer inom sjukvård, tjänsteförmedling inom rese- och byggbranschen samt handel med värdepapper och därmed förenlig verksamhet.
Address
Alstigen 2
Email
jatros.nord@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 560 | 2 099 | 3 209 | 3 334 | 2 618 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −400 | −85 | 61 | 459 | −395 |
| Depreciation & amort. | −0 | −0 | −0 | −12 | −12 |
| EBIT | −400 | −85 | 61 | 447 | −407 |
| Net financials | −58 | −72 | −80 | −101 | −83 |
| Profit before tax | −458 | −157 | −20 | 346 | −489 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −458 | −157 | −20 | 346 | −489 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 418 | 651 | 485 | 618 | 425 |
| Equity | −406 | −564 | −583 | −238 | −727 |
| Long-term debt | 281 | 497 | 316 | 140 | 269 |
| Short-term debt | 543 | 718 | 752 | 716 | 884 |
| Total debt | 824 | 1 215 | 1 068 | 856 | 1 153 |
EBITDA margin
-15.1%
This company
15.8%
Market median
-196% vs market
20202024
Equity ratio
-171.1%
This company
38.2%
Market median
-548% vs market
20202024
Return on equity
-48900000.0%
This company
18.4%
Market median
-265760970% vs market
20202024
Net profit margin
-18.7%
This company
8.1%
Market median
-331% vs market
20202024
Asset turnover
6.16×
This company
1.12×
Market median
+450% vs market
20202024
Debt / equity
1.58×
This company
0.62×
Market median
-155% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LÅ Audit | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Jatros nord AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Åke Ahlert | Audit | 0 companies |
| Jacek Andrzej Jackowski | Board of Directors | 0 companies |
| Beata Anna Romanowska Benjaminsson | Deputy Board Member | 0 companies |